They’re saving us from COVID-19, is influenza next for mRNA vaccines?

The technology could be revolutionary, with some scientists suggesting it could be used to treat cancers
Professor Nigel McMillan
Professor Nigel McMillan.

Until last year, pharma company Moderna seemed to be a toxic investment story you read about only if you thumbed through the business pages of your newspaper.

It had been around for a decade without managing to get a single drug approved, it had lost about $2 billion and it was only sustained through the life-support of repeated capital raising.